BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25465576)

  • 1. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology.
    Miller MM; Burton ME; Johnson PN; Miller JL
    Am J Health Syst Pharm; 2014 Dec; 71(24):2108-9. PubMed ID: 25465576
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the Relationship between FEV
    Hoff BM; Scheetz MH; Jain M; Cullina JF; Rhodes NJ
    Pharmacotherapy; 2020 Jun; 40(6):584-591. PubMed ID: 32259317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of aminoglycosides in the neonate: a review.
    Pacifici GM
    Eur J Clin Pharmacol; 2009 Apr; 65(4):419-27. PubMed ID: 19104791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily versus pharmacokinetic dosing of aminoglycosides.
    Medicus-Bringa M; Ward G; Rice M
    Am J Med; 1997 Oct; 103(4):328-30. PubMed ID: 9382126
    [No Abstract]   [Full Text] [Related]  

  • 6. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 6. Aminoglycosides.
    Marchand S; Boisson M; Mehta S; Adier C; Mimoz O; Grégoire N; Couet W
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycosides: another look at current and future roles in antimicrobial therapy.
    Murphy JE
    Pharmacotherapy; 1990; 10(3):217-23. PubMed ID: 2196537
    [No Abstract]   [Full Text] [Related]  

  • 9. Once-daily aminoglycosides.
    Nicolau D; Quintiliani R; Nightingale CH
    Conn Med; 1992 Oct; 56(10):561-3. PubMed ID: 1458882
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 11. Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth.
    Allegaert K; Anderson BJ
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1011-2. PubMed ID: 17006675
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.
    Mathews A; Bailie GR
    J Clin Pharm Ther; 1987 Oct; 12(5):273-91. PubMed ID: 3119606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside pharmacokinetics in neonates: the need to search for covariates of variability in addition to case descriptions.
    Allegaert K
    Acta Paediatr; 2009 Oct; 98(10):1546; author reply 1546-7. PubMed ID: 19659582
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates.
    Valitalo PA; van den Anker JN; Allegaert K; de Cock RF; de Hoog M; Simons SH; Mouton JW; Knibbe CA
    J Antimicrob Chemother; 2015 Jul; 70(7):2074-7. PubMed ID: 25766737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.
    Ohler KH; Menke JA; Fuller L
    Am J Perinatol; 2000; 17(6):285-90. PubMed ID: 11144309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
    Mareville J; Gay J; Cliquennois E; Herbaux C; Pasquier F; Allorge D; Blondiaux N; Berthon C; Alfandari S
    Scand J Infect Dis; 2012 May; 44(5):398-401. PubMed ID: 22235869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.
    Perry AC; Rouse MS; Khaliq Y; Piper KE; Hanssen AD; Osmon DR; Steckelberg JM; Patel R
    Clin Orthop Relat Res; 2002 Oct; (403):49-53. PubMed ID: 12360007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More on variability in aminoglycoside volume of distribution.
    Dasta JF; Armstrong DK
    Clin Pharm; 1987 Mar; 6(3):193. PubMed ID: 3665376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.